Is Erythromycin + Sulfisoxazole registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Erythromycin + Sulfisoxazole.

Active substances

Erythromycin + Sulfisoxazole

SFDA 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
PEDIAZOLE GRANULES FOR SUSPENSION	40, 120 mg/ml	Granules for oral suspension · Oral use	1 Bottle	SAR 27.30	NCE · Prescription	Abbott Laboratories	Withdrawn by MAH · Not Marketed

Components

Erythromycin

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.